Literature DB >> 10159726

Development of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST).

L Demers1, R Weiss-Lambrou, B Ska.   

Abstract

This study's purpose was to develop a clinical instrument designed to evaluate user satisfaction with assistive technology devices. This paper describes the methodology used to develop the instrument entitled the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST). Based on the theoretical and practical foundations of assistive technology as well as on the concept of satisfaction, preliminary versions of the instrument were created and examined by a panel of team participants. After the panel's recommendations were incorporated, a pretest of the revised instrument was conducted and the final French version of QUEST emerged. The originality of QUEST lies in its inter-activeness and user-directed approach to assessing satisfaction with assistive technology. From a set of 27 variables, the user is asked to indicate the degree of importance he/she attributes to each of the satisfaction variables and then to rate his/her degree of satisfaction with each of the variables considered (quite or very) important. While QUEST remains a clinical instrument undergoing pilot testing, it holds much promise in our quest for a reliable and valid means of assessing assistive technology outcome from the user's perspective.

Entities:  

Mesh:

Year:  1996        PMID: 10159726     DOI: 10.1080/10400435.1996.10132268

Source DB:  PubMed          Journal:  Assist Technol        ISSN: 1040-0435


  33 in total

1.  A quality-of-life scale for assistive technology: results of a pilot study of aging and technology.

Authors:  Emily M Agree; Vicki A Freedman
Journal:  Phys Ther       Date:  2011-10-14

2.  Satisfaction and use of personal emergency response systems.

Authors:  B Heinbüchner; M Hautzinger; C Becker; K Pfeiffer
Journal:  Z Gerontol Geriatr       Date:  2010-08       Impact factor: 1.281

3.  Exploratory study of perceived quality of life with implanted standing neuroprostheses.

Authors:  Loretta M Rohde; Bette R Bonder; Ronald J Triolo
Journal:  J Rehabil Res Dev       Date:  2012

4.  Measuring wheelchair intervention outcomes: development of the wheelchair outcome measure.

Authors:  William B Mortenson; William C Miller; Jan Miller-Pogar
Journal:  Disabil Rehabil Assist Technol       Date:  2007-09

5.  On the way home: a BCI-FES hand therapy self-managed by sub-acute SCI participants and their caregivers: a usability study.

Authors:  Anna Zulauf-Czaja; Manaf K H Al-Taleb; Mariel Purcell; Nina Petric-Gray; Jennifer Cloughley; Aleksandra Vuckovic
Journal:  J Neuroeng Rehabil       Date:  2021-02-25       Impact factor: 4.262

6.  Initial constructs for patient-centered outcome measures to evaluate brain-computer interfaces.

Authors:  Elena M Andresen; Melanie Fried-Oken; Betts Peters; Donald L Patrick
Journal:  Disabil Rehabil Assist Technol       Date:  2015-03-25

7.  Satisfaction with participation using a manual wheelchair among individuals with spinal cord injury.

Authors:  P W Rushton; W C Miller; W B Mortenson; J Garden
Journal:  Spinal Cord       Date:  2010-02-02       Impact factor: 2.772

8.  Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods: study protocol.

Authors:  Alejandro Rodríguez-Molinero; Jorge Hernández-Vara; Antonio Miñarro; Carlos Pérez-López; Àngels Bayes-Rusiñol; Juan Carlos Martínez-Castrillo; David A Pérez-Martínez
Journal:  BMJ Open       Date:  2021-07-19       Impact factor: 2.692

9.  Head-mounted Visual Assistive Technology-related Quality of Life Changes after Telerehabilitation.

Authors:  Marie-Céline Lorenzini; Walter Wittich
Journal:  Optom Vis Sci       Date:  2021-06-01       Impact factor: 1.973

10.  Personalized Telerehabilitation for a Head-mounted Low Vision Aid: A Randomized Feasibility Study.

Authors:  Marie-Céline Lorenzini; Walter Wittich
Journal:  Optom Vis Sci       Date:  2021-06-01       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.